Good reporting practice Record enzyme source, substrate concentrations, SAM concentration, buffer, temperature, readout method, and salt-equivalent concentration whenever potency is compared
Unlike full-length HGH, AOD-9604 does not interact with growth hormone receptors, meaning it does not induce unwanted side effects such as insulin resistance or water retention
This region-specific action is associated with its local stimulation of hormone-sensitive lipase and enhanced fatty acid oxidation, suggesting potential for site-selective metabolic modulation without systemic hormonal changes
KLOW Dosage and Frequency Chart The standard KLOW protocol uses a 3.2 mg dose, or a 10-unit draw from an 80 mg KLOW vial reconstituted with 2.5 mL BAC water
Rotating sites may reduce irritation when multiple injections are needed